Andrew Reilly
Partner
Over the past 28 years, Andrew Reilly has represented Australian and New Zealand companies on more than 2,000 offers of debt and equity securities in the United States. He also advises underwriters and placement agents ranging from boutique to “bulge bracket” investment banks.
Andrew’s practice focuses on US securities and corporate law matters. He advises on private placements, Rule 144A transactions and US public offers of debt and equity securities, including Nasdaq listings. He also advises on re-domiciliation of Australian companies to Delaware, commercial matters, bank finance and cross-border M&A transactions.
In addition to providing US securities law advice, Andrew works with local lawyers around the world to provide clients with expert international securities law advice in a convenient and cost-efficient manner.
REPRESENTATIVE MATTERS
- US tranche of Australian IPOs for companies such as Carbon Revolution, Cettire, Clarity Pharmaceuticals, PointsBet, Trajan and Touch Ventures
- Equity placements for companies such as Charter Hall Retail REIT, Resolute Mining and Vicinity
- Entitlement offers for companies such as Aristocrat, Core Lithium, Emeco, National Storage REIT, Nickel Mines and Sandfire Resources
- Nasdaq listings for companies such as Benitec Biopharma, Incannex Healthcare, Lonestar Resources, Radiopharm Theranostics and Sundance Energy
- US public offers and compliance advice for Nasdaq-listed companies such as Bionomics, Kazia Therapeutics, Immutep and Mesoblast
- Level 1 American Depositary Receipt programs for companies such as Air New Zealand, Fletcher Building, Lynas, Qantas and Redbubble
- Quotation of ordinary shares on OTCQX for companies such as Ecograf, PointsBet, Sayona Mining, Splitit and Tinybeans
- Re-domiciliation to Delaware with listing on Nasdaq for companies such as Bionomics, Incannex Healthcare, Piedmont Lithium, Lonestar Resources and Sundance Energy
- Australian IPOs of US companies such as EBR Systems and Keypath Education
- Securities law aspects of acquisitions of companies such as Templeton Global Growth Fund and Saracen Mineral
- US private placements of debt for companies such as Downer, Fletcher Building, Melbourne Airport, Mighty River Power and Vector
- Rule 144A high-yield bond offers for companies such as Barminco, Bemax, Griffin Coal, Fortescue and TFS Corporation
- Rule 144A investment-grade bond offers for companies such as Foster’s, Qantas and Suncorp
- Convertible bond offers for companies such as Kangaroo Resources, Oxiana and Valad
PROFESSIONAL HONORS AND AWARDS
- Best Lawyers in Australia, Equity Capital Markets, 2025
- Chambers and Partners, Band 2, Capital Markets, US Law, 2025
- Lexology (Formerly Who’s Who Legal), Capital Markets – Debt and Equity, 2025
PUBLICATIONS
News, Events, & Insights
- Neuphoria Therapeutics Ring the Nasdaq Opening Bell
News March 6, 2025
- US Debt and Equity Offers by Australian and New Zealand Issuers in 2024
Insights February 12, 2025
- Rimon advises Aussie biotech on re-domiciliation and listing on Nasdaq as a Delaware company
News January 23, 2025
- Agriculture & Natural Solutions Acquisition Corporation Announces US$510 Million Business Combination
News September 3, 2024
- US Subsidiaries of Australian Companies - Beneficial Ownership Reporting Requirements
Insights August 15, 2024
- US Debt and Equity Offers by Australian and New Zealand Issuers in 2023
Insights February 13, 2024
